These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32469451)

  • 1. Autologously Humanized Mice for Immune-Oncologic Studies.
    Fu J; Kim YJ
    Curr Protoc Pharmacol; 2020 Jun; 89(1):e76. PubMed ID: 32469451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous reconstitution of human cancer and immune system in vivo.
    Fu J; Sen R; Masica DL; Karchin R; Pardoll D; Walter V; Hayes DN; Chung CH; Kim YJ
    Oncotarget; 2017 Jan; 8(2):2053-2068. PubMed ID: 28008146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
    Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
    Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
    Marín-Jiménez JA; Capasso A; Lewis MS; Bagby SM; Hartman SJ; Shulman J; Navarro NM; Yu H; Rivard CJ; Wang X; Barkow JC; Geng D; Kar A; Yingst A; Tufa DM; Dolan JT; Blatchford PJ; Freed BM; Torres RM; Davila E; Slansky JE; Pelanda R; Eckhardt SG; Messersmith WA; Diamond JR; Lieu CH; Verneris MR; Wang JH; Kiseljak-Vassiliades K; Pitts TM; Lang J
    Front Immunol; 2021; 12():607282. PubMed ID: 33854497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.
    Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A
    Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
    Verma B; Wesa A
    Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
    Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
    Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment.
    Chiorazzi M; Martinek J; Krasnick B; Zheng Y; Robbins KJ; Qu R; Kaufmann G; Skidmore Z; Juric M; Henze LA; Brösecke F; Adonyi A; Zhao J; Shan L; Sefik E; Mudd J; Bi Y; Goedegebuure SP; Griffith M; Griffith O; Oyedeji A; Fertuzinhos S; Garcia-Milian R; Boffa D; Detterbeck F; Dhanasopon A; Blasberg J; Judson B; Gettinger S; Politi K; Kluger Y; Palucka K; Fields RC; Flavell RA
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37487666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the BLT humanized mouse as a stem cell based gene therapy tumor model.
    Vatakis DN; Bristol GC; Kim SG; Levin B; Liu W; Radu CG; Kitchen SG; Zack JA
    J Vis Exp; 2012 Dec; (70):e4181. PubMed ID: 23271478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
    Brendel C; Rio P; Verhoeyen E
    Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.
    Morton JJ; Bird G; Keysar SB; Astling DP; Lyons TR; Anderson RT; Glogowska MJ; Estes P; Eagles JR; Le PN; Gan G; McGettigan B; Fernandez P; Padilla-Just N; Varella-Garcia M; Song JI; Bowles DW; Schedin P; Tan AC; Roop DR; Wang XJ; Refaeli Y; Jimeno A
    Oncogene; 2016 Jan; 35(3):290-300. PubMed ID: 25893296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patients.
    Werner-Klein M; Proske J; Werno C; Schneider K; Hofmann HS; Rack B; Buchholz S; Ganzer R; Blana A; Seelbach-Göbel B; Nitsche U; Männel DN; Klein CA
    PLoS One; 2014; 9(5):e97860. PubMed ID: 24830425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.
    Reinisch A; Thomas D; Corces MR; Zhang X; Gratzinger D; Hong WJ; Schallmoser K; Strunk D; Majeti R
    Nat Med; 2016 Jul; 22(7):812-21. PubMed ID: 27213817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer.
    Tentler JJ; Lang J; Capasso A; Kim DJ; Benaim E; Lee YB; Eisen A; Bagby SM; Hartman SJ; Yacob BW; Gittleman B; Pitts TM; Pelanda R; Eckhardt SG; Diamond JR
    BMC Cancer; 2020 Nov; 20(1):1063. PubMed ID: 33148223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-Bone Marrow Transplantation of Endosteal Bone Marrow Cells Facilitates Allogeneic Hematopoietic and Stromal Cells Engraftment Dependent on Early Expression of CXCL-12.
    Chen C; Su Y; Chen J; Zhang D; Song Y; Guo S
    Med Sci Monit; 2015 Sep; 21():2757-66. PubMed ID: 26373579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human proangiogenic circulating hematopoietic stem and progenitor cells promote tumor growth in an orthotopic melanoma xenograft model.
    Mund JA; Shannon H; Sinn AL; Cai S; Wang H; Pradhan KR; Pollok KE; Case J
    Angiogenesis; 2013 Oct; 16(4):953-62. PubMed ID: 23877751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.
    Meraz IM; Majidi M; Meng F; Shao R; Ha MJ; Neri S; Fang B; Lin SH; Tinkey PT; Shpall EJ; Morris J; Roth JA
    Cancer Immunol Res; 2019 Aug; 7(8):1267-1279. PubMed ID: 31186248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity.
    Cai S; Wang H; Bailey B; Ernstberger A; Juliar BE; Sinn AL; Chan RJ; Jones DR; Mayo LD; Baluyut AR; Goebel WS; Pollok KE
    Clin Cancer Res; 2011 Apr; 17(8):2195-206. PubMed ID: 21487065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.
    Zhao Y; Shuen TWH; Toh TB; Chan XY; Liu M; Tan SY; Fan Y; Yang H; Lyer SG; Bonney GK; Loh E; Chang KTE; Tan TC; Zhai W; Chan JKY; Chow EK; Chee CE; Lee GH; Dan YY; Chow PK; Toh HC; Lim SG; Chen Q
    Gut; 2018 Oct; 67(10):1845-1854. PubMed ID: 29602780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.